BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22892601)

  • 41. Translocation renal cell carcinomas in adults: a single-institution experience.
    Zhong M; De Angelo P; Osborne L; Paniz-Mondolfi AE; Geller M; Yang Y; Linehan WM; Merino MJ; Cordon-Cardo C; Cai D
    Am J Surg Pathol; 2012 May; 36(5):654-62. PubMed ID: 22446944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal cell carcinoma with t(6:11) (p21;q12). A case report highlighting distinctive immunohistologic features of this rare tumor.
    Arneja SK; Gujar N
    Int J Surg Case Rep; 2015; 7C():16-9. PubMed ID: 25562596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha gene upregulates TFEB expression in renal cell carcinoma with t(6;11) translocation, which promotes cell canceration.
    Zhan HQ; Li ST; Shu Y; Liu MM; Qin R; Li YL; Gan L
    Int J Oncol; 2018 Mar; 52(3):933-944. PubMed ID: 29328409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [TFEB-amplified renal cell carcinoma. A case report and review of the literature].
    Mayoral Guisado C; Gómez Durán Á; Agustín Benítez López D; Toro Zambrano W; Rubio Fernández A; Moreno Ontalba A; Díaz Delgado M
    Rev Esp Patol; 2018; 51(4):248-252. PubMed ID: 30269777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sclerosing TFEB-rearrangement renal cell carcinoma: a recurring histologic pattern.
    Williamson SR; Eble JN; Palanisamy N
    Hum Pathol; 2017 Apr; 62():175-179. PubMed ID: 27864122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphologic and Immunohistochemical Characteristics of Fluorescent In Situ Hybridization Confirmed TFE3-Gene Fusion Associated Renal Cell Carcinoma: A Single Institutional Cohort.
    Akgul M; Saeed O; Levy D; Mann SA; Cheng L; Grignon DJ; Eble JN; Idrees MT
    Am J Surg Pathol; 2020 Nov; 44(11):1450-1458. PubMed ID: 32701515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.
    Argani P; Zhang L; Reuter VE; Tickoo SK; Antonescu CR
    Am J Surg Pathol; 2017 May; 41(5):655-662. PubMed ID: 28296677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH.
    Xia QY; Wang XT; Ye SB; Wang X; Li R; Shi SS; Fang R; Zhang RS; Ma HH; Lu ZF; Shen Q; Bao W; Zhou XJ; Rao Q
    Histopathology; 2018 Apr; 72(5):786-794. PubMed ID: 29148086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis?
    Williamson SR; Grignon DJ; Cheng L; Favazza L; Gondim DD; Carskadon S; Gupta NS; Chitale DA; Kalyana-Sundaram S; Palanisamy N
    Am J Surg Pathol; 2017 Mar; 41(3):287-298. PubMed ID: 28009604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: a comparative study.
    Lobo J; Rechsteiner M; Helmchen BM; Rupp NJ; Weber A; Moch H
    Histopathology; 2022 Jul; 81(1):32-43. PubMed ID: 35403742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.
    Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; Pivovarčikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O
    Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spectrum of biphasic renal cell carcinomas with hyalinized stroma and psammoma bodies associated and not associated with NF2 alteration.
    Chumbalkar V; Wang P; Paner GP
    Hum Pathol; 2022 Mar; 121():11-18. PubMed ID: 34929230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Translocational renal cell carcinoma (t(6;11)(p21;q12) with transcription factor EB (TFEB) amplification and an integrated precision approach: a case report.
    Lilleby W; Vlatkovic L; Meza-Zepeda LA; Revheim ME; Hovig E
    J Med Case Rep; 2015 Dec; 9():281. PubMed ID: 26654961
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal carcinoma with (6;11)(p21;q12) translocation: report of an adult case.
    Ishihara A; Yamashita Y; Takamori H; Kuroda N
    Pathol Int; 2011 Sep; 61(9):539-45. PubMed ID: 21884304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Melanotic MiT family translocation neoplasms: Expanding the clinical and molecular spectrum of this unique entity of tumors.
    Saleeb RM; Srigley JR; Sweet J; Doucet C; Royal V; Chen YB; Brimo F; Evans A
    Pathol Res Pract; 2017 Nov; 213(11):1412-1418. PubMed ID: 28969862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.
    Kato I; Furuya M; Baba M; Kameda Y; Yasuda M; Nishimoto K; Oyama M; Yamasaki T; Ogawa O; Niino H; Nakaigawa N; Yano Y; Sakamoto K; Urata Y; Mikami K; Yamasaki S; Tanaka R; Takagi T; Kondo T; Nagashima Y
    Histopathology; 2019 Aug; 75(2):254-265. PubMed ID: 30908700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations.
    Wang XM; Shao L; Xiao H; Myers JL; Pantanowitz L; Skala SL; Udager AM; Vaishampayan U; Mannan R; Dhanasekaran SM; Chinnaiyan AM; Betz BL; Brown N; Mehra R
    Am J Clin Pathol; 2023 Dec; 160(6):549-554. PubMed ID: 37499055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary retroperitoneal renal cell carcinoma associated with transcription EB gene fusion.
    Liu Z; Hua X
    Minerva Med; 2024 Feb; 115(1):32-36. PubMed ID: 32239878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms.
    Caliò A; Marletta S; Brunelli M; Pedron S; Portillo SC; Segala D; Bariani E; Gobbo S; Netto G; Martignoni G
    Virchows Arch; 2022 Dec; 481(6):877-891. PubMed ID: 35980471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal cell carcinoma with t(6;11) translocation: a patient case with a novel Alpha-TFEB fusion point.
    Zhan HQ; Wang CF; Zhu XZ; Xu XL
    J Clin Oncol; 2010 Dec; 28(34):e709-13. PubMed ID: 20823414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.